Syndicate Bio

Empowering Personalized Healthcare and Advancing Precision Medicine

Newark, United States · Founded 2024 · $120K raised

Headquarters
Newark, Delaware
Employees
1–10
Founded
2024
Business Model
B2B
Total Funding
$120K
Last Round
$120K SeedSep 2024
Rounds
1

About

Syndicate Bio is a genomics and precision medicine company building Africa's largest genomic reference database to bridge the data gap in precision medicine. The company offers genetic testing services including hereditary cancer screening, non-invasive prenatal testing (NIPT), somatic cancer testing, and pharmacogenomic testing. Operating through its 'Direct by Syndicate Bio' consumer brand, the company brings world-class genetic testing directly to individuals, families, and healthcare providers across Africa.

Summary

Syndicate Bio is a Healthcare company based in Newark, United States, founded in 2024. It has raised $120K in total across 1 round, most recently a $120K Seed round in Sep 2024. Investors include Techstars.

Tech & App Stack

1 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundSep 2024
$120K

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Syndicate Bio on Indexed.vc
<a href="https://indexed.vc/companies/syndicate-bio"><img src="https://indexed.vc/api/badge/company/syndicate-bio" alt="Syndicate Bio on Indexed.vc" width="260" height="76" /></a>